The abrogation of macrophage migration inhibition by pretreatment of immune exudate cells with anti-theta antibody and complement.
D000818:Animals; D000906:Antibodies; D000918:Antibody Specificity; D000921:Antibody-Producing Cells; D000961:Antilymphocyte Serum; D001202:Ascitic Fluid / Q000166:cytology; D002464:Cell Migration Inhibition; D002469:Cell Separation; D003165:Complement System Proteins; D005898:Glass; D006462:Hemolytic Plaque Technique; D006736:Horses / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007106:Immune Sera; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D008805:Mice, Inbred A; D008806:Mice, Inbred AKR; D008809:Mice, Inbred C3H; D011817:Rabbits / Q000276:immunology; D013154:Spleen / Q000166:cytology; D013950:Thymus Gland / Q000166:cytology / Q000276:immunology; D013954:Thyroglobulin / Q000302:isolation & purification
D000906:Antibodies; D000961:Antilymphocyte Serum; D007106:Immune Sera; D003165:Complement System Proteins; D013954:Thyroglobulin